Tetrahydroindole and Tetrahydroindazole Derivatives
申请人:Huang Kenneth He
公开号:US20080269193A1
公开(公告)日:2008-10-30
The invention provides indole and indazole compounds of Formula (I)
or pharmaceutically acceptable salts thereof which are useful for treating and/or preventing diseases and/or disorders ameliorated by the inhibition of Heat-Shock Protein 90. The invention further provides pharmaceutical compositions comprising compounds of Formula (I) and methods of preparing compounds of Formula (I).
Polyfluoroarenes. Part XVII. Some reactions of pentafluorobenzonitrile
作者:J. M. Birchall、R. N. Haszeldine、M. E. Jones
DOI:10.1039/j39710001343
日期:——
Pentafluorobenzonitrile reacts with ammonia, aniline, and o-phenylenediamine and with chloride, bromide, iodide, methoxide, hydroxide, acetate, benzoate, and azide ions mainly by displacement of the 4-fluorine atom. Reaction with an excess of chloride ion yields pentachlorobenzonitrile. Tetrafluoro-4-iodobenzonitrile undergoes attack at the iodine atom itself in the presence of iodide ion, and 4-b
TETRAHYDROINDOLE AND TETRAHYDROINDAZOLE DERIVATIVES
申请人:Serenex, Inc.
公开号:EP2146967A2
公开(公告)日:2010-01-27
[EN] TETRAHYDROINDOLE AND TETRAHYDROINDAZOLE DERIVATIVES<br/>[FR] DÉRIVÉS DE TÉTRAHYDROINDOLE ET DE TÉTRAHYDROINDAZOLE
申请人:SERENEX INC
公开号:WO2008130879A2
公开(公告)日:2008-10-30
[EN] The invention provides indole and indazole compounds of Formula (I) or pharmaceutically acceptable salts thereof which are useful for treating and/or preventing diseases and/or disorders ameliorated by the inhibition of Heat-Shock Protein 90. The invention further provides pharmaceutical compositions comprising compounds of Formula (I) and methods of preparing compounds of Formula (I). [FR] L'invention concerne des composés d'indole et d'indazole de formule (I) ou leurs sels pharmaceutiquement acceptables. Les composés selon l'invention sont utiles pour le traitement et/ou la prévention de maladies et/ou de troubles améliorés par l'inhibition de la protéine Hsp90 (Heat-Shock Protein 90). L'invention concerne également des compositions pharmaceutiques qui comprennent des composés de formule (I) et des procédés de préparation des composés de formule (I).